Home
Drugs
fluorouracil
Clinical Trials

Clinical Trials Related to fluorouracil

Related studies linked through entity extraction aliases.

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)

Status: NOT_YET_RECRUITING
Phase: PHASE3

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Status: NOT_YET_RECRUITING
Phase: PHASE1/PHASE2

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer ( EV-309 )

Status: RECRUITING
Phase: PHASE3

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

Status: RECRUITING
Phase: PHASE1

A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma

Status: NOT_YET_RECRUITING
Phase: PHASE2/PHASE3

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Status: NOT_YET_RECRUITING
Phase: PHASE1/PHASE2

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Status: RECRUITING
Phase: PHASE2

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Status: RECRUITING
Phase: PHASE3

Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE1

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2/PHASE3

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Status: RECRUITING
Phase: PHASE1

AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas

Status: NOT_YET_RECRUITING
Phase: PHASE2

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Status: RECRUITING
Phase: NA

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

Status: NOT_YET_RECRUITING
Phase: PHASE3

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Status: RECRUITING
Phase: PHASE1/PHASE2

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Status: RECRUITING
Phase: PHASE3

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Status: RECRUITING
Phase: PHASE3

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Status: RECRUITING
Phase: PHASE3

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Status: RECRUITING
Phase: PHASE2